SCHEMBL30762537

SCHEMBL30762537

CC(=O)c1cc(Cl)cc2c(C#N)cc(N3CCOCC3)nc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.49
▸ ATM Q13315 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ ATR Q13535 3/20 0.45
▸ ATRIP Q8WXE1 1/20 0.45
▸ ALDH1A1 P00352 4/20 0.42
▸ MAPK1 P28482 2/20 0.41
▸ KMT2A Q03164 4/20 0.41
▸ MEN1 O00255 3/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ PIK3CA P42336 2/20 0.40
▸ KDM4E B2RXH2 2/20 0.39
▸ THRB P10828 2/20 0.39
▸ GAA P10253 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ PPARG P37231 2/20 0.39
▸ PKM P14618 1/20 0.39
▸ POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30762469 0.89 ALDH1A1 (0.50) HTTATML3MBTL1ALDH1A1MAPK1
SCHEMBL30762505 0.88 L3MBTL1 (0.50) HTTATML3MBTL1ATRATRIP
SCHEMBL30762426 0.87 KMT2A (0.40) HTTATML3MBTL1ATRATRIP
SCHEMBL30762601 0.84 HTT (0.47) HTTATML3MBTL1ATRATRIP
SCHEMBL30762411 0.81 HTT (0.54) HTTATML3MBTL1ATRATRIP
SCHEMBL30762530 0.80 HTT (0.49) HTTATML3MBTL1ATRATRIP
SCHEMBL30762629 0.79 ALDH1A1 (0.45) HTTL3MBTL1ALDH1A1MAPK1KMT2A
SCHEMBL30762375 0.78 HTT (0.49) HTTATML3MBTL1ATRATRIP
SCHEMBL30762588 0.77 KDM4E (0.53) HTTATML3MBTL1ALDH1A1MAPK1
SCHEMBL30762409 0.76 ALDH1A1 (0.54) L3MBTL1ALDH1A1MAPK1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024026423-A1 SUBSTITUTED QUINOLINE DERIVATIVES AS PI3K INHIBITORS BLACK DIAMOND THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
Send feedback